ELV - Company ID 0001156039
The table below shows Elevance Health, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $50.18B | $50.71B | $49.78B | $48.89B | $45.11B | $43.89B |
| Cost of revenue | $5.46B | $5.38B | $5.29B | $4.98B | $5.09B | $4.82B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
Elevance Health, Inc. reported annual revenue of $199.13B for fiscal year 2025. That is up 12.5% from $177.01B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $84.86B (FY 2016) to $199.13B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $6.33B |
| $5.27B |
| $5.00B |
| $5.30B |
| $5.27B |
| $5.07B |
| Operating income | $2.09B | $1.29B | $2.42B | $3.17B | $1.41B | $2.77B |
| Income tax | $544.00M | $219.00M | $548.00M | $613.00M | $365.00M | $685.00M |
| Net income | $1.76B | $1.19B | $1.74B | $2.18B | $1.02B | $2.30B |
| EPS (diluted) | $8.00 | $5.32 | $7.72 | $9.61 | $4.36 | $9.85 |